Immunotherapy with conventional type-1 dendritic cells induces immune memory and limits tumor relapse
Abstract The potential of dendritic cell (DC) vaccination against cancer is not fully achieved. Little is known about the precise nature of the anti-cancer immune response triggered by different natural DC subsets and their relevance in preventing postsurgical tumor recurrence. Here, we use mouse sp...
Saved in:
| Main Authors: | Ignacio Heras-Murillo, Diego Mañanes, Pablo Munné, Vanessa Núñez, Jessica Herrera, Mauro Catalá-Montoro, Maite Alvarez, Miguel A. del Pozo, Ignacio Melero, Stefanie K. Wculek, David Sancho |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-58289-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The significance of the omentum in locoregional immunotherapy for peritoneal carcinomatosis
by: Ángela Bella, et al.
Published: (2023-12-01) -
Dendritic Cell-Based Immunotherapy: The Importance of Dendritic Cell Migration
by: Min-Seon Song, et al.
Published: (2024-01-01) -
GDF‐15 blockade: A multi‐directional approach to potentiate cancer immunotherapy and alleviate cancer cachexia
by: Ignacio Melero, et al.
Published: (2025-04-01) -
Dendritic Cell-Based Immunotherapy for Prostate Cancer
by: Hanka Jähnisch, et al.
Published: (2010-01-01) -
Cytokine-overexpressing dendritic cells for cancer immunotherapy
by: Joonsu Han, et al.
Published: (2024-12-01)